Document ID: chunk:federal_register_of_legislation:C2021A00139:clause:1_79
Version: federal_register_of_legislation:C2021A00139
Segment Type: clause
Provision Reference: sch 1 cl 79
Character Range: 41301–42585

79  At the end of section 99ADH
Add:

12.5% average unadjusted price reduction test
 (6) For the purposes of this section, a brand of a pharmaceutical item passes the 12.5% average unadjusted price reduction test if there have been 3 consecutive data collection periods in respect of which a weighted average disclosed price has been determined for any brand of the pharmaceutical item, where:
 (a) the percentage obtained by dividing the total of the unadjusted price reductions for a brand of the pharmaceutical item in respect of each of those data collection periods by 3 is at least 12.5%; and
 (b) this section did not apply to the brand of the pharmaceutical item in relation to any of those data collection periods; and
 (c) those data collection periods include the data collection period mentioned in paragraph (1)(a).
 (7) For the purposes of subsection (6), if the Minister determines the weighted average disclosed price of a brand of a pharmaceutical item in respect of a data collection period for the brand, the unadjusted price reduction for the brand of the pharmaceutical item in respect of the data collection period is the unadjusted price reduction for the brand of the pharmaceutical item when the determination came into force.
Note: See subsection 99ADB(4).